Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study

Yonemori, K; Kuboki, Y; Hasegawa, K; Iwata, T; Kato, H; Takehara, K; Hirashima, Y; Kato, H; Passey, C; Buchbjerg, JK; Harris, JR; Andreassen, CM; Nicacio, L; Soumaoro, I; Fujiwara, K

Yonemori, K (通讯作者)，Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

CANCER SCIENCE, 2022; 113 (8): 2788

Abstract

New treatments, particularly second-line options, are needed to improve outcomes for patients with recurrent/metastatic cervical cancer (r/mCC). Tisot......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索